These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
123 related items for PubMed ID: 8723187
1. BQ-123, a specific endothelin (ETA) receptor antagonist, prevents ischemia-reperfusion injury in kidney transplantation. Büyükgebiz O, Aktan AO, Haklar G, Yalçin AS, Yeğen C, Yalin R, Ercan ZS. Transpl Int; 1996; 9(3):201-7. PubMed ID: 8723187 [Abstract] [Full Text] [Related]
2. The effects of thromboxane synthase inhibition on reperfusion injury and endothelin-1,2 levels in allograft kidney transplantation in rats. Büyükgebiz O, Aktan AO, Haklar G, Bilsel S, Dülger M. Res Exp Med (Berl); 1999 Apr; 198(6):289-98. PubMed ID: 10369085 [Abstract] [Full Text] [Related]
5. Selective endothelin a (ETA) receptor antagonist (BQ-123) reduces both myocardial infarct size and oxidant injury. Ozdemir R, Parlakpinar H, Polat A, Colak C, Ermis N, Acet A. Toxicology; 2006 Feb 15; 219(1-3):142-9. PubMed ID: 16406210 [Abstract] [Full Text] [Related]
6. Reversal of established responses to endothelin-1 in vivo and in vitro by the endothelin receptor antagonists, BQ-123 and PD 145065. Warner TD, Allcock GH, Vane JR. Br J Pharmacol; 1994 May 15; 112(1):207-13. PubMed ID: 8032643 [Abstract] [Full Text] [Related]
9. Prevention of cold ischaemia-reperfusion injury by an endothelin receptor antagonist in experimental renal transplantation. Herrero I, Torras J, Riera M, Condom E, Coll O, Cruzado JM, Hueso M, Bover J, Lloberas N, Alsina J, Grinyó JM. Nephrol Dial Transplant; 1999 Apr 15; 14(4):872-80. PubMed ID: 10328462 [Abstract] [Full Text] [Related]
14. Endothelin receptor antagonist BQ-123 ameliorates myocardial ischemic-reperfusion injury in rats: a hemodynamic, biochemical, histopathological and electron microscopic evidence. Goyal SN, Bharti S, Arora S, Golechha M, Arya DS. Biomed Pharmacother; 2010 Nov 15; 64(9):639-46. PubMed ID: 20888175 [Abstract] [Full Text] [Related]
15. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats. Hocher B, Rohmeiss P, Zart R, Diekmann F, Vogt V, Metz D, Fakhury M, Gretz N, Bauer C, Koppenhagen K, Neumayer HH, Distler A. Cardiovasc Res; 1996 Apr 15; 31(4):499-510. PubMed ID: 8689641 [Abstract] [Full Text] [Related]
16. Protective effect of a selective endothelin receptor antagonist, BQ-123, in ischemic acute renal failure in rats. Mino N, Kobayashi M, Nakajima A, Amano H, Shimamoto K, Ishikawa K, Watanabe K, Nishikibe M, Yano M, Ikemoto F. Eur J Pharmacol; 1992 Oct 06; 221(1):77-83. PubMed ID: 1459192 [Abstract] [Full Text] [Related]
19. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. Mister M, Noris M, Szymczuk J, Azzollini N, Aiello S, Abbate M, Trochimowicz L, Gagliardini E, Arduini A, Perico N, Remuzzi G. Kidney Int; 2002 Mar 06; 61(3):1064-78. PubMed ID: 11849462 [Abstract] [Full Text] [Related]
20. Effects of BQ-123, an ETA recepter-selective antagonist, on changes of intraocular pressure, blood-aqueous barrier and aqueous prostaglandin concentrations caused by endothelin-1 in rabbit. Haque MS, Sugiyama K, Taniguchi T, Kitazawa Y. Jpn J Ophthalmol; 1996 Mar 06; 40(1):26-32. PubMed ID: 8739497 [Abstract] [Full Text] [Related] Page: [Next] [New Search]